Selected News from Today's FirstWord

Bristol-Myers Squibb's fourth-quarter profit rises, misses estimates

Bristol-Myers Squibb's fourth-quarter profit reached $852 million, up from $483 million in the year-ago period, although the figure fell short of analysts' estimates due partly to lower-than-expected sales of Plavix. Quarterly revenue for the drug, which is marketed with Sanofi, slipped 3 percent to $1.7 billion. Full story

Also in the News

FirstWord Dossier Reports
www.fwreports.com

**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com

FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.

Click here to see our recent reports.

Most Read Stories in the Past Week

Recent Reports